Skip to main content

Yolanda Cámara Navarro

Institutions of which they are part

Main researcher
Neuromuscular and Mitochondrial Pathology
Vall Hebron Institut de Recerca

Yolanda Cámara Navarro

Institutions of which they are part

Main researcher
Neuromuscular and Mitochondrial Pathology
Vall Hebron Institut de Recerca

Projects

Estudio preclínico del tratamiento del MNGIE mediante terapia génica, usando un vector lentivírico en un modelo murino. Seguimiento a largo plazo y bajo sobrecarga de timidina

IP: Ramon Martí Seves
Collaborators: Yolanda Cámara Navarro
Funding agency: Instituto de Salud Carlos III
Funding: 126445
Reference: PI09/01591
Duration: 01/01/2010 - 31/12/2012

Patologia Neuromuscular i Mitocondrial

IP: Antonio Luis Andreu Périz
Collaborators: Elena García Arumí, Yolanda Cámara Navarro, Mª Jesus Melia Grimal, Tomàs Pinós Figueras, Marc Cuadros Arasa, Ramon Martí Seves
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2009 SGR 1520
Duration: 01/01/2010 - 30/04/2014

Related news

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

The newly developed analytical workflow could in the future be introduced as a comprehensive diagnostic test for patients with mitochondrial diseases.

Related professionals

Victor Guerra Ruiz

Victor Guerra Ruiz

Research technician
Pneumology
Read more
Judit Garcia Simancas

Judit Garcia Simancas

Reconstructive Surgery of the Locomotor System
Read more
Montserrat Buaki Sogó

Montserrat Buaki Sogó

Research technician
Molecular Medical Imaging
Read more
Mireia Santos Montes

Mireia Santos Montes

Medium Grade Technician
Clinical Trials Management Unit
Clinical Research Development Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.